BEAMing sheds light on drug resistance.
BEAMing sheds light on drug resistance.
复制标题
DOI：
10.1158/1078-0432.ccr-11-2556
复制
发表时间：
2011-12-15
期刊：
影响因子：
--
通讯作者：
Park BH
中科院分区：
文献类型：
--
作者：
Lauring J;Park BH
Targeted therapies against somatically altered genes are currently used for the treatment of many human cancers. The nascent technology, BEAMing, has potential to increase the clinical utility of these agents as it allows for the detection of cancer mutations in peripheral blood, providing a rapid assessment of tumor mutation status.
